Forskolin, a Potent Adenylate Cyclase Activator, Lowers Rabbit Intraocular Pressure
- 1 January 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 102 (1) , 146-148
- https://doi.org/10.1001/archopht.1984.01040030124051
Abstract
• To our knowledge, this is the first report of a topically applied, specific adenylate cyclase activator that reduces intraocular pressure. Forskolin, a novel adenylate cyclase activator, is reported to increase cyclic adenosine monophosphate (AMP) in intact cells. Cyclic AMP levels are increased with various antiglaucoma agents. Intraocular pressure in rabbits was significantly reduced with two concentrations of forskolin, 0.1% and 0.05%. Ocular hypertension was noted with 0.5% and 0.2%. No change in IOP was noted with 0.01% forskolin. The IOP lowering with 0.1% and 0.05% forskolin lasted approximately six hours. Mild, transient conjunctival chemosis was noted in the doses that decreased IOP. The contralateral control eye showed decreases in IOP, but the differences between control and tested eyes were significant by the Student's pairedttest.Keywords
This publication has 3 references indexed in Scilit:
- Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.Proceedings of the National Academy of Sciences, 1981
- Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrierExperimental Eye Research, 1977
- Cyclic-AMP in the aqueous humor: The effects of adrenergic agentsExperimental Eye Research, 1972